• 1. Fate of single walled carbon nanotubes in wetland ecosystems?
  Joseph H. Bisesi,Tara Sabo-Attwood Environ. Sci.: Nano, 2014,1, 574-583
• 2. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 3. Enabling chloride salts for thermal energy storage: implications of salt purity?
  J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608
• 4. Enabling non-flammable Li-metal batteries via electrolyte functionalization and interface engineering?
  Jing Yu,Yu-Qi Lyu,Jiapeng Liu,Mohammed B. Effat,Junxiong Wu J. Mater. Chem. A, 2019,7, 17995-18002
• 5. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466

• Other Chemical Reagents Derivatization Reagents
• Solvents and Organic Chemicals Organic Compounds Acids/Esters

Introduction to (3-(ethylsulfonyl)phenyl)boronic Acid (CAS No. 845870-47-5)

(3-(ethylsulfonyl)phenyl)boronic acid, with the chemical identifier CAS No. 845870-47-5, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical chemistry and materials science. This compound belongs to the class of boronic acids, which are well-known for their versatile applications in medicinal chemistry, particularly in the design and synthesis of targeted drug therapies.

The structure of (3-(ethylsulfonyl)phenyl)boronic acid features a phenyl ring substituted with an ethylsulfonyl group and a boronic acid functional group. The presence of the boronic acid moiety makes this compound a valuable intermediate in Suzuki-Miyaura cross-coupling reactions, a pivotal method in organic synthesis that facilitates the formation of carbon-carbon bonds. These reactions are widely employed in the construction of complex molecular architectures, including those found in pharmaceuticals.

In recent years, there has been a surge in research focused on boronic acid derivatives due to their unique biochemical properties. Boronic acids can form reversible covalent bonds with diols, a characteristic that has been exploited in various therapeutic applications. For instance, (3-(ethylsulfonyl)phenyl)boronic acid has shown promise in the development of inhibitors for enzymes that are involved in inflammatory pathways. Its ability to interact with biological targets makes it a candidate for designing novel therapeutic agents.

One of the most compelling aspects of (3-(ethylsulfonyl)phenyl)boronic acid is its potential in drug discovery and development. The ethylsulfonyl group introduces a certain level of electronic and steric influence on the phenyl ring, which can be fine-tuned to optimize binding affinity and selectivity. This feature is particularly important in medicinal chemistry, where subtle structural modifications can significantly impact the efficacy and safety of a drug candidate.

Recent studies have highlighted the role of boronic acids in targeted therapy, especially in oncology. Compounds like (3-(ethylsulfonyl)phenyl)boronic acid have been investigated for their potential to inhibit key enzymes overexpressed in cancer cells. The reversible binding capability of boronic acids allows for tight control over drug release, minimizing off-target effects and reducing toxicity. This characteristic aligns well with the growing demand for precision medicine approaches.

The synthesis of (3-(ethylsulfonyl)phenyl)boronic acid involves multi-step organic transformations, typically starting from readily available aromatic precursors. The introduction of the ethylsulfonyl group requires careful control of reaction conditions to ensure high yield and purity. Advanced synthetic techniques, such as palladium-catalyzed cross-coupling reactions, have been instrumental in achieving efficient and scalable production processes.

In addition to its pharmaceutical applications, (3-(ethylsulfonyl)phenyl)boronic acid has found utility in materials science. Boronic acids are known to form coordination complexes with metals, which can be leveraged in the development of novel catalysts and functional materials. The unique properties of these complexes make them attractive for applications ranging from sensors to nanotechnology.

The chemical reactivity of (3-(ethylsulfonyl)phenyl)boronic acid also extends to its potential use as a building block for more complex molecules. Its ability to participate in cross-coupling reactions allows chemists to construct intricate molecular frameworks with precision. This flexibility is particularly valuable in drug design, where complex scaffolds are often required to achieve optimal pharmacological profiles.

Evaluation studies on (3-(ethylsulfonyl)phenyl)boronic acid have demonstrated its stability under various conditions, making it a reliable component in synthetic protocols. Furthermore, its compatibility with green chemistry principles is noteworthy, as many synthetic routes can be optimized to minimize waste and energy consumption. This aligns with global efforts to promote sustainable chemical practices.

The future prospects for (3-(ethylsulfonyl)phenyl)boronic acid are promising, given its diverse range of applications and ongoing research efforts. As our understanding of biochemical pathways continues to evolve, new opportunities for therapeutic intervention will emerge. The compound's unique properties position it as a key player in next-generation drug development.

• 373384-18-0((3-methanesulfonylphenyl)boronic acid)
• 1175560-85-6(4-(Cyclopropylmethylsulfonyl)phenylboronic acid)
• 1217501-02-4(4-(Butylsulfonyl)phenylboronic acid)
• 1217500-99-6(4-(Isobutylsulfonyl)phenylboronic acid)
• 1217501-07-9(4-(Cyclopropylsulfonyl)phenylboronic acid)
• 149104-88-1(4-(Methylsulfonyl)phenylboronic acid)
• 1217501-34-2(4-(Propylsulfonyl)phenylboronic acid)
• 850567-98-5((4-isopropylsulfonylphenyl)boronic acid)
• 352530-24-6(4-(ethylsulfonyl)phenylboronicacid)
• 863248-21-9(4-Ethylsulfinylphenylboronic acid)